Skip to main content
Annals of Intensive Care
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study

Fig. 2

Forrest plot of the impact of monotherapy and combination therapy on the clinical outcomes of patients with S. maltophilia-HAP by treatment propensity score analysis. Figure legend Propensity score analyses indicated that in the overall patient cohort, patients with APACHE II scores < 15, and immunocompetent individuals, combination treatment was associated with comparable 30-day mortality, clinical response, and microbiologic eradication outcomes, whereas it was associated with reduced 30-day mortality risk, higher 30-day clinical response rates, and improved 30-day microbiologic eradication outcomes among individuals with APACHE II scores ≥ 15 and immunocompromised individuals

Back to article page